Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
Plos One|August 15, 2015
Simultaneous Hypoxia and Low Extracellular pH Suppress Overall Metabolic Rate and Protein Synthesis In VitroBrita Singers Sørensen, Morten Busk, Jens Overgaard, et al.
International Journal of Radiation Oncology, Biology, Physics|June 7, 2005
Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumorsMichael Sørensen, Michael R Horsman, Paul Cumming, et al.
International Journal of Radiation Biology|March 10, 2006
Relationship between radiobiological hypoxia in a C3H mouse mammary carcinoma and osteopontin levels in mouse serumSlavka Lukacova, Azza A Khalil, Jens Overgaard, et al.
Acta Oncologica (Stockholm, Sweden)|December 14, 2011
Tumourigenicity and radiation resistance of mesenchymal stem cellsFilippo P D'Andrea, Michael R Horsman, Moustapha Kassem, et al.
The Lancet. Oncology|October 4, 2005
Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trialJens Overgaard, Jesper Grau Eriksen, Marianne Nordsmark, et al.
Acta Oncologica (Stockholm, Sweden)|May 1, 2010
Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitroBrita Singers Sørensen, Kasper Toustrup, Michael R Horsman, et al.
International Journal of Molecular Sciences|July 10, 2020
Tumors Resistant to Checkpoint Inhibitors Can Become Sensitive after Treatment with Vascular Disrupting AgentsMichael R Horsman, Thomas R Wittenborn, Patricia S Nielsen, et al.
Acta Oncologica (Stockholm, Sweden)|September 5, 2008
The effect of combretastatin A4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on water diffusion and blood perfusion in tumoursGang Chen, Michael R Horsman, Michael Pedersen, et al.
Anticancer Research|May 13, 2015
Uniform Combretastatin-induced Effect on Monocytes and Neutrophils in Peripheral Blood but Not in TumorsAnja B Bohn, Anne S Brems-Eskildsen, Bjarne K Møller, et al.
European Journal of Pharmacology|September 18, 2012
The vascular-disrupting agent, combretastatin-A4-phosphate, enhances neurogenic vasoconstriction in rat small arteriesJunjing Su, Britt E Laursen, Yvonne Eskildsen-Helmond, et al.
Pageof 12